Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The EBITDA margin is N/A as of Tuesday, October 6, 2026.
EBITDA MARGIN
N/A
Market Cap
$3.04M
EBITDA Margin
-22711.52%
TTM Avg
-15924.10%
3Y Avg
-12940.13%
5Y Avg
-12940.13%
Market Cap
$3.01M
EBITDA Margin
-4291.67%
TTM Avg
-3563.06%
3Y Avg
-8274.29%
5Y Avg
-15578.54%
Market Cap
$3.13M
EBITDA Margin
-437.97%
TTM Avg
-452.41%
3Y Avg
-479.95%
5Y Avg
-376.71%
Market Cap
$3.25M
EBITDA Margin
-7.62%
TTM Avg
-1345.01%
3Y Avg
-903.09%
5Y Avg
-551.32%
Market Cap
$3.27M
EBITDA Margin
-2030.10%
TTM Avg
-2765.29%
3Y Avg
-1907.45%
5Y Avg
-2238.98%
Market Cap
$2.77M
EBITDA Margin
-375.69%
TTM Avg
-244.00%
3Y Avg
-166.51%
5Y Avg
-121.60%
Market Cap
$2.84M
EBITDA Margin
-13.43%
TTM Avg
-23.07%
3Y Avg
-17.91%
5Y Avg
-1.28%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Revelation Biosciences, Inc. (REVB) | $3.05M | N/A | N/A | N/A | N/A |
| Adagio Medical Holdings, Inc. (ADGM)vs › | $3.04M | -22711.52% | -15924.10% | -12940.13% | -12940.13% |
| BioRestorative Therapies, Inc. (BRTX)vs › | $3.01M | -4291.67% | -3563.06% | -8274.29% | -15578.54% |
| IceCure Medical Ltd (ICCM)vs › | $3.13M | -437.97% | -452.41% | -479.95% | -376.71% |
| MBody AI Ltd. (MBAI)vs › | $3.16M | N/A | N/A | N/A | N/A |
| Paranovus Entertainment Technology Ltd. (PAVS)vs › | $3.25M | -7.62% | -1345.01% | -903.09% | -551.32% |
| Aethlon Medical, Inc. (AEMD)vs › | $3.27M | -2030.10% | -2765.29% | -1907.45% | -2238.98% |
| iSpecimen Inc. (ISPC)vs › | $2.77M | -375.69% | -244.00% | -166.51% | -121.60% |
| Universe Pharmaceuticals Inc. (UPC)vs › | $2.84M | -13.43% | -23.07% | -17.91% | -1.28% |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs › | $3.53M | N/A | N/A | N/A | N/A |
Gross Margin
0.0%
EBITDA Margin
N/A
Operating Margin
0.0%
Net Margin
0.0%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
